Thrive – Redle Pharmaceuticals

Opposed App ID 4762602 Class 5 Word

Trademark information

IP India · live record
Application ID
4762602
Status
Opposed
Sub status
Not Applicable
Date of application
30 November 2020
Classes
5
Type
Word
Proprietor
Redle Pharmaceuticals Private Unit No.611, Reliables Pride, Anand Nagar, Opp. Heera Panna, Jogeshwari West, Mumbai 400102, Mah
Agent
Rekhi Vishakha A Singh[32014]A 903, Julian Apls, Bhakti Park, Near Imax Theatre, Wadala(east), Mumbai 400037.
State
Maharashtra
Filing mode
e-Filing
IP office
Mumbai
Used since
29 January 2018
Valid / upto
—

Goods & services

Class 5

Class 5AYURVEDIC MEDICINAL PRODUCTS, NUTRITIONAL SUPPLEMENTS, PHARMACEUTICAL PREPARATIONS INCLUDED IN CLASS 05

Uploaded documents

Sign in to open
1 TM-A(TRADE MARKS APPLICATION) 30 Nov 2020
2 Reply to Exam Report (MIS-R) 21 Dec 2020
3 Documents in support of Show cause Hearing (SCH) 20 Apr 2023
4 Documents in support of Show cause Hearing (SCH) 20 Apr 2023
5 Documents in support of Show cause Hearing (SCH) 20 Apr 2023
6 Documents in support of Show cause Hearing (SCH) 20 Apr 2023
7 Documents in support of Show cause Hearing (SCH) 20 Apr 2023
8 Documents in support of Show cause Hearing (SCH) 20 Apr 2023
9 Documents in support of Show cause Hearing (SCH) 20 Apr 2023
10 Documents in support of Show cause Hearing (SCH) 20 Apr 2023
11 Letter 21 Apr 2023
11 Authorization Letter 21 Apr 2023
12 Letter 21 Apr 2023
12 Authorization Letter 21 Apr 2023
13 Letter 21 Apr 2023
13 Authorization Letter 21 Apr 2023
14 TM-O(NOTICE OF OPPOSITION) 28 Feb 2024
15 TM-O(NOTICE OF OPPOSITION) 04 Jun 2024
16 Journal Copy 07 Jun 2024
17 Evidence Affidavit Under Rule 46 (TOP) 08 Apr 2025
18 Annexure -1 under rule 46 08 Apr 2025

Correspondence and notices

1 EXAMINATION REPORT 10809160 11 Dec 2020
2 Hearing Notice (Show Cause) 13169776 11 Mar 2022
3 Hearing Notice (Show Cause) 14731190 01 Feb 2023
4 Tribunal Accepted Notice for : 4762602 17211088 · 6487925 24 Jan 2024
5 Opposition Notice 18728785 · 6877673 21 Aug 2024
6 Opposition Notice 18728818 · 6877676 21 Aug 2024
7 Opposition Counter Statement 19451667 · 7061407 07 Jan 2025
8 Opposition Counter Statement 19454143 · 7061623 08 Jan 2025
9 Hearing Notice 21435885 · 7541819 29 Dec 2025
10 General Order 21794543 · 7630704 12 Feb 2026

Frequently asked questions

Thrive was applied for on 30 November 2020.

The application was filed by Redle Pharmaceuticals.

Class 5.

As per IP India, the status is Opposed.

The listed application ID of Thrive is 4762602.

Trademark attorney Rekhi Vishakha A Singh.